KEYMED BIO-B 02162·

Gross margin --------84.40%--97.42%13.01%89.59%7.83%97.15%7.57%87.71%9.44% Net margin -1070.71%---1987.98%917.27%-3530.12%1542.15%-303.41%3226.72%-101.04%202.36%-120.27%19.23%-72.96%47.31% ROE 60.70%--74.79%14.09%-106.47%181.26%-9.22%97.25%-12.03%2.81%-20.82%8.79%-18.84%1.98% ROA -25.44%---154.52%129.08%-98.94%55.58%-7.72%91.22%-9.21%1.49%-13.67%4.46%-12.39%1.28% Revenue growth ----163.28%--167.71%4.43%-9.26%176.96%253.87%263.13%20.91%232.97%67.31%46.41% Attributable profit growth -----388.67%---374.88%13.79%92.07%466.96%-16.63%108.70%-43.38%26.75%-1.44%41.94% Debt-to-assets 141.90%--306.59%164.69%7.35%299.24%15.08%7.74%23.08%8.00%34.28%11.21%34.21%0.08% Current ratio 7.24--4.752.4931.9627.218.7223.249.360.643.306.062.900.40 Operating cash flow / net profit 0.41--0.150.260.060.091.321.270.850.481.530.681.360.17 Operating cash flow / revenue -437.07%---289.78%147.28%-194.65%95.13%-401.68%207.03%-85.75%315.94%-184.44%98.70%-99.45%84.99%

Gross margin 93.29%--80.76%12.53% Net margin -15.80%--197.32%213.12% Revenue growth ----23.72%-- Attributable profit growth ----1644.14%-- Debt-to-assets ----29.33%-- Current ratio ----4.83-- Operating cash flow / net profit 2.30---0.212.51 Operating cash flow / revenue -36.29%---41.16%4.87%

Revenue 15.64M--41.19M163.28%110.27M167.71%100.06M9.26%354.10M253.87%428.12M20.91%716.31M67.31% Other income and gains --------52.67M--259.00M391.77%123.25M52.41%141.15M14.53%159.22M12.80% Gross profit --------93.07M--97.48M4.74%317.22M225.42%415.92M31.12%628.26M51.05% Selling and distribution expenses --------------------110.90M--321.99M190.35% Administrative expenses 15.16M--21.55M42.16%92.45M329.06%133.91M44.84%177.01M32.18%187.93M6.17%182.21M3.05% Net finance costs 5.68M--14.31M152.05%11.13M22.20%8.40M24.58%17.26M105.54%18.46M6.96%16.91M8.41% Income tax 0--0----------1.60M--6.26M291.98%1.87M70.06% Operating profit ---------3.88B---285.49M92.64%-334.18M17.06%-484.93M45.11%-503.14M3.76% Share of associates and JVs ---------719.00K---9.71M1250.63%-4.75M51.11%-5.26M10.70%-674.00K87.18% Profit before tax -167.51M---818.85M388.83%-3.89B375.38%-303.60M92.20%-356.19M17.32%-508.65M42.80%-520.72M2.37% Net profit -167.51M---818.85M388.83%-3.89B375.38%-303.60M92.20%-357.79M17.85%-514.91M43.92%-522.60M1.49% Net profit attributable to owners -167.51M---818.58M388.67%-3.89B374.88%-308.12M92.07%-359.36M16.63%-515.24M43.38%-522.64M1.44%

Revenue 498.75M--617.07M23.72% Other income and gains 75.54M--1.71B2158.28% Cost of sales 33.48M--118.74M254.71% Gross profit 465.28M--498.32M7.10% Selling and distribution expenses 137.58M--218.39M58.74% Administrative expenses 89.26M--85.55M4.15% Net finance costs 7.46M--6.38M14.55% Income tax 3.13M--290.15M9155.31% Share of associates and JVs -566.00K---401.00K29.15% Profit before tax -75.66M--1.51B2092.71% Net profit -78.80M--1.22B1645.21% Net profit attributable to owners -78.84M--1.22B1644.14%

Cash and cash equivalents 432.61M--199.41M53.91%1.52B662.56%604.07M60.27%851.03M40.88%418.41M50.83%503.35M20.30% Trade and bills receivables ----------------16.09M--62.85M290.60%100.85M60.46% Inventories 3.31M--6.85M107.08%16.39M139.45%44.49M171.43%56.35M26.65%111.42M97.72%195.98M75.89% Total current assets 518.40M--380.92M26.52%3.58B840.35%3.31B7.59%2.94B11.19%2.47B16.11%2.42B1.75% Total assets 658.58M--529.95M19.53%3.93B642.43%3.93B0.05%3.88B1.26%3.77B3.00%4.22B11.97% Total current liabilities 71.59M--80.24M12.08%112.08M39.67%379.70M238.79%314.18M17.26%747.73M137.99%836.29M11.84% Total liabilities 934.53M--1.62B73.86%289.07M82.21%593.10M105.17%896.11M51.09%1.29B44.11%1.44B11.71% Equity attributable to owners -275.95M---1.09B296.64%3.65B433.56%3.34B8.51%2.99B10.60%2.47B17.14%2.77B12.11% Total equity -275.95M---1.09B296.73%3.65B432.97%3.34B8.40%2.99B10.55%2.48B17.13%2.77B12.11%

Cash and cash equivalents ----2.34B-- Trade and bills receivables ----210.27M-- Inventories ----230.28M-- Total current assets ----3.94B-- Total assets ----5.67B-- Total current liabilities ----816.55M-- Total liabilities ----1.66B-- Equity attributable to owners ----4.01B-- Total equity ----4.01B--

Net cash from operating activities -68.38M---119.36M74.56%-214.64M79.82%-401.93M87.26%-303.62M24.46%-789.63M160.07%-712.41M9.78% Net cash from investing activities -58.02M---113.07M94.88%-2.04B1700.60%-645.59M68.29%468.20M172.52%67.71M85.54%39.08M42.29% Net cash from financing activities 505.07M--7.40M98.54%3.64B49087.18%-8.06M100.22%72.13M995.04%283.90M293.59%788.72M177.82% Net change in cash 378.67M---225.03M159.43%1.39B716.74%-1.06B176.06%236.71M122.43%-438.03M285.05%115.39M126.34%

Net cash from operating activities -181.00M---254.00M40.33% Net cash from investing activities -200.00M--2.21B1203.00% Net cash from financing activities 886.00M---103.00M111.63%